Treatment of thromboangiitis obliterans by removal of autoantibodies
US8663147B2 · kind B2 · utility
0Cited by
2References
14Claims
0Family size
Inventor
Key dates
| Filing date | Apr 20, 2009 |
| Grant date | Mar 4, 2014 |
| Priority date | — |
| Expiry date | Apr 20, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T29/49826
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a specific ligand for antibodies, preferably autoantibodies in the manufacture of a column for the treatment of thromboangiitis obliterans. The invention pertains furthermore to the apharesis column with at least one anti-IgG antibody for the treatment of thromboangiitis obliterans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.